Document Detail

Cardiac resynchronization therapy: an updateimpaired left ventricular systolic function.
MedLine Citation:
PMID:  21285934     Owner:  NLM     Status:  In-Data-Review    
Cardiac resynchronization therapy has been shown to reduce hospitalization and mortality, and to improve heart failure symptoms, in patients with systolic dysfunction and ventricular dyssynchrony. We review the current guidelines for cardiac resynchronization therapy, the underlying evidence, the latest developments in the field and directions of future research.
N V Garikipati; M J Schaefer; J S Steinberg
Related Documents :
11586954 - Pregnancy-associated plasma protein a as a marker of acute coronary syndromes.
24102864 - Maternal floor infarction: management of an underrecognized pathology.
2354714 - Anti-ischemic and antianginal effects of 60 mg isosorbide-5-mononitrate in patients tre...
15495294 - Interregional differences in health in slovenia. i. estimated prevalence of selected ca...
9474644 - Left origin of the atrial esophageal signal as recorded in the pacing site.
22882964 - Severity of left ventricular dysfunction in heart failure patients affects the degree o...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Minerva cardioangiologica     Volume:  59     ISSN:  0026-4725     ISO Abbreviation:  Minerva Cardioangiol     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400725     Medline TA:  Minerva Cardioangiol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  89-100     Citation Subset:  IM    
Division of Cardiology, Al-Sabah Arrhythmia Institute, St. Luke's and Roosevelt Hospitals, Columbia University College of Physicians & Surgeons, New York, NY, USA -
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cardiogenic shock: role of revascularization.
Next Document:  Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus.